Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
Jessica MandrioliSara Angela MalerbaEttore BeghiNicola FiniAntonio FasanoElisabetta ZucchiSilvia De PasquaCarlo GuidiEmilio TerlizziElisabetta SetteAlessandro RavasioMario CasmiroFabrizio SalviRocco LiguoriLucia ZinnoYasmin HandoukRomana RizziAnnamaria BorghiRita RinaldiDoriana MediciMario SantangeloEnrico GranieriVittoria MussutoMarina AielloSalvatore FerroMarco Vincetinull nullPublished in: Journal of neurology (2018)
Independently from other prognostic factors, patients who received riluzole for a longer period of time survived longer, but further population based studies are needed to verify if long-tem use of riluzole prolongs survival.